These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38148258)

  • 1. Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Am J Surg; 2024 Apr; 230():63-67. PubMed ID: 38148258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Surgery; 2024 Mar; 175(3):695-703. PubMed ID: 37863686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Access to Hospitals Most Ready to Achieve National Accreditation for Rectal Cancer Treatment.
    Antunez AG; Kanters AE; Regenbogen SE
    JAMA Surg; 2019 Jun; 154(6):516-523. PubMed ID: 30785616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgeon-Level Variation in Utilization of Local Staging and Neoadjuvant Therapy for Stage II-III Rectal Adenocarcinoma.
    Swords DS; Skarda DE; Sause WT; Gawlick U; Cannon GM; Lewis MA; Scaife CL; Gygi JA; Tae Kim H
    J Gastrointest Surg; 2019 Apr; 23(4):659-669. PubMed ID: 30706375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare population with pancreatic cancer.
    Fong ZV; Chang DC; Hur C; Jin G; Tramontano A; Sell NM; Warshaw AL; Fernandez-Del Castillo C; Ferrone CR; Lillemoe KD; Qadan M
    Am J Surg; 2020 Jul; 220(1):29-34. PubMed ID: 32265013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Fragmentation of Care in Locally Advanced Rectal Cancer Increase Patient Mortality?
    Freischlag K; Olivere L; Turner M; Adam M; Mantyh C; Migaly J
    J Gastrointest Surg; 2021 May; 25(5):1287-1296. PubMed ID: 32754789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
    Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
    Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Commission on Cancer Accreditation on Cancer Survival: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis.
    Ahmed A; Whittington J; Shafaee Z
    Ann Surg Oncol; 2024 Apr; 31(4):2286-2294. PubMed ID: 38093167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
    Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
    Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Commission on Cancer Accreditation Status, Hospital Rurality and Hospital Size on Quality Measure Performance Rates.
    Schroeder MC; Gao X; Lizarraga I; Kahl AR; Charlton ME
    Ann Surg Oncol; 2022 Apr; 29(4):2527-2536. PubMed ID: 35067792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Center Volume and Type Impact Stage-Specific Utilization of Neoadjuvant Therapy in Rectal Cancer.
    Midura EF; Jung AD; Daly MC; Hanseman DJ; Davis BR; Shah SA; Paquette IM
    Dig Dis Sci; 2017 Aug; 62(8):1906-1912. PubMed ID: 28501970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragmented care, Commission on Cancer accreditation, and overall survival in patients receiving surgery and chemotherapy for esophageal cancer.
    Verm RA; Baker MM; Cohn T; Park S; Swanson J; Freeman R; Abdelsattar ZM
    Surgery; 2024 Mar; 175(3):618-628. PubMed ID: 37743107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
    Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
    Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide Heterogeneity in Hospital-Specific Probabilities of Rectal Cancer Understaging and Its Effects on Outcomes.
    Becerra AZ; Wexner SD; Dietz DW; Xu Z; Aquina CT; Justiniano CF; Swanger AA; Temple LK; Noyes K; Monson JR; Fleming FJ
    Ann Surg Oncol; 2018 Aug; 25(8):2332-2339. PubMed ID: 29850952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragmented Care in the Treatment of Rectal Cancer and Time to Definitive Therapy.
    Abelson JS; Bauer PS; Barron J; Bommireddy A; Chapman WC; Schad C; Ohman K; Hunt S; Mutch M; Silviera M
    J Am Coll Surg; 2021 Jan; 232(1):27-33. PubMed ID: 33190785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer.
    Freischlag K; Sun Z; Adam MA; Kim J; Palta M; Czito BG; Migaly J; Mantyh CR
    JAMA Surg; 2017 Jun; 152(6):558-564. PubMed ID: 28273303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facility Variation in Local Staging of Rectal Adenocarcinoma and its Contribution to Underutilization of Neoadjuvant Therapy.
    Swords DS; Brooke BS; Skarda DE; Stoddard GJ; Tae Kim H; Sause WT; Scaife CL
    J Gastrointest Surg; 2019 Jun; 23(6):1206-1217. PubMed ID: 30421120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.
    Delitto D; George TJ; Loftus TJ; Qiu P; Chang GJ; Allegra CJ; Hall WA; Hughes SJ; Tan SA; Shaw CM; Iqbal A
    J Natl Cancer Inst; 2018 May; 110(5):460-466. PubMed ID: 29165692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.